Whether AP-1 functions as a tumor promoter or a tumor suppressor depends on the antagonistic activity of diverse AP-1 proteins, on the type of the malignancy, the stage of the disease and, finally, the genetic landscape of the tumor [44,45]. This evidence concerns the gene JUNB and neoplasm.